Zeng J - Search Results

1

Does Neutron Radiation Therapy Potentiate an Immune Response to Merkel Cell Carcinoma?

Schaub SK, Stewart RD, Sandison GA, Arbuckle T, Liao JJ, Laramore GE, Zeng J, Rengan R, Tseng YD, Mayr NA, Bhatia S, Nghiem PT, Parvathaneni U. Schaub SK, et al. Among authors: zeng j. Int J Part Ther. 2018 Summer;5(1):183-195. doi: 10.14338/IJPT-18-00012.1. Epub 2018 Sep 21. Int J Part Ther. 2018. PMID: 31773029 Free PMC article.

2

Combination of stereotactic ablative body radiation with targeted therapies.

Zeng J, Baik C, Bhatia S, Mayr N, Rengan R. Zeng J, et al. Lancet Oncol. 2014 Sep;15(10):e426-34. doi: 10.1016/S1470-2045(14)70026-9. Lancet Oncol. 2014. PMID: 25186046 Review.

3

An image-guided precision proton radiation platform for preclinical in vivo research.

Ford E, Emery R, Huff D, Narayanan M, Schwartz J, Cao N, Meyer J, Rengan R, Zeng J, Sandison G, Laramore G, Mayr N. Ford E, et al. Among authors: zeng j. Phys Med Biol. 2017 Jan 7;62(1):43-58. doi: 10.1088/1361-6560/62/1/43. Epub 2016 Dec 14. Phys Med Biol. 2017. PMID: 27973343

4

Framework for radiation pneumonitis risk stratification based on anatomic and perfused lung dosimetry.

Dhami G, Zeng J, Vesselle HJ, Kinahan PE, Miyaoka RS, Patel SA, Rengan R, Bowen SR. Dhami G, et al. Among authors: zeng j. Strahlenther Onkol. 2017 May;193(5):410-418. doi: 10.1007/s00066-017-1114-0. Epub 2017 Mar 2. Strahlenther Onkol. 2017. PMID: 28255667 Free PMC article. Clinical Trial.

5

Functional lung avoidance and response-adaptive escalation (FLARE) RT: Multimodality plan dosimetry of a precision radiation oncology strategy.

Lee E, Zeng J, Miyaoka RS, Saini J, Kinahan PE, Sandison GA, Wong T, Vesselle HJ, Rengan R, Bowen SR. Lee E, et al. Among authors: zeng j. Med Phys. 2017 Jul;44(7):3418-3429. doi: 10.1002/mp.12308. Epub 2017 Jun 1. Med Phys. 2017. PMID: 28453861 Free PMC article.

6

Dose Escalation Optimization in Patients With Locally Advanced Non-Small-Cell Lung Cancer: The Right Dose, in the Right Location, to the Right Patient, at the Right Time.

Zeng J, Rengan R. Zeng J, et al. JAMA Oncol. 2017 Oct 1;3(10):1365-1367. doi: 10.1001/jamaoncol.2017.1344. JAMA Oncol. 2017. PMID: 28570727 No abstract available.

7

The relationship between cardiac radiation dose and mediastinal lymph node involvement in stage III non-small cell lung cancer patients.

McNew LK, Bowen SR, Gopan O, Nyflot MJ, Patel SA, Zeng J, Rengan R. McNew LK, et al. Among authors: zeng j. Adv Radiat Oncol. 2017 Feb 1;2(2):192-196. doi: 10.1016/j.adro.2017.01.008. eCollection 2017 Apr-Jun. Adv Radiat Oncol. 2017. PMID: 28740931 Free PMC article.

8

Proton Therapy for Malignant Pleural Mesothelioma: A Three Case Series Describing the Clinical and Dosimetric Advantages of Proton-Based Therapy.

Lee H, Zeng J, Bowen SR, Rengan R. Lee H, et al. Among authors: zeng j. Cureus. 2017 Sep 20;9(9):e1705. doi: 10.7759/cureus.1705. Cureus. 2017. PMID: 29159011 Free PMC article.

9

Challenge of Proving the Value of Proton Therapy in an Unselected Patient Population in the Era of Precision Oncology: The Fallacy of a One-Size-Fits-All Strategy in Radiotherapy for Lung Cancer.

Rengan R, Redman M, Zeng J. Rengan R, et al. Among authors: zeng j. J Clin Oncol. 2018 Jul 1;36(19):2003-2004. doi: 10.1200/JCO.2018.78.3803. Epub 2018 May 10. J Clin Oncol. 2018. PMID: 29746228 No abstract available.

10

Proton therapy in non-small cell lung cancer.

Rengan R, Zeng J. Rengan R, et al. Among authors: zeng j. Transl Lung Cancer Res. 2018 Apr;7(2):103-105. doi: 10.21037/tlcr.2018.04.13. Transl Lung Cancer Res. 2018. PMID: 29876308 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

10,191 results

Search Page

Filters